Ledger.Open graph →

SEC Form D · Amendment · filed March 18, 2015

Serina Therapeutics, Inc

Offering

$6.3M

Sold

$4.9M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

HUNTSVILLE, AL

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Randall W. Moreadith · Huntsville, ALExec · Director Barbara M. Fisk · Madison, ALDirector James R. Hudson, Jr · Huntsville, ALDirector Michael D. Bentley · Huntsville, ALExec · Director Tacey R. Viegas · Madison, ALExec J M. Harris · Huntsville, ALExec · Director Michael D. Barnes · Washington, Washington, D.C.Exec · Director Nancy C. Floyd · Washington, Washington, D.C.Director Vincent L. Ammann · Washington, Washington, D.C.Exec · Director Roberta W. Sims · Washington, Washington, D.C.Director George P. Clancy · Washington, Washington, D.C.Exec J M. Harris · Huntsville, ALExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗